Harvard University - Dana-Farber Cancer Institute, Mayo Clinic - Department of Health Science Research, Harvard University - Dana-Farber Cancer Institute, Harvard University - Dana-Farber Cancer Institute, Harvard University - Dana-Farber Cancer Institute, Monash University, Cardiff University and Velindre Cancer Centre, West Cancer Center and Research Institute, Ospedale San Martino - Medical Oncology Unit, KU Leuven, West Virginia University Cancer Institute and the Mary Babb Randolph Cancer Center, University of Antwerp - Multidisciplinary Oncologic Centre Antwerp (MOCA), Vall d’Hebron Institute of Oncology (VHIO)Hospital Vall d’Hebron, University of Leeds - Institute of Oncology, Memorial Sloan Kettering Cancer Center, University of Pennsylvania Perelman School of Medicine - Abramson Cancer Center, Instituto CUF de Oncologia, Pfizer, Inc. - Global Product Development, University Medical Center Utrecht - Department of Medical Oncology, Martin Luther University, Mayo Clinic - Department of Oncology, University of São Paulo (USP) - Instituto do Cancer do Estado de Sao Paulo, University of Sydney Medical School, University of Pisa - Department of Oncology, University General Hospital of Heraklion - Department of Medical Oncology, Universitatsklinikum Hamburg-Eppendorf, LMU Munich - Department of Hematology/Oncology, National Cancer Center Hospital East, Institut Franco-Britannique - Department of Medical Oncology, Institut Franco-Britannique - Department of Medical Oncology, Mayo Clinic - Department of Health Science Research and NIHR Clinical Research Network, Leeds

WIN Consortium - Worldwide Innovative Network (WIN) Association, Groupe Hospitalier Saint-Joseph, École Normale Supérieure - PSL Research University - Institut Curie, Pfizer, Inc., AstraZeneca Pharmaceuticals, WIN Consortium - Worldwide Innovative Network (WIN) Association, WIN Consortium - Worldwide Innovative Network (WIN) Association, Avera Cancer Institute, WIN Consortium - Worldwide Innovative Network (WIN) Association, Hebrew University of Jerusalem - The Sharett Institute of Oncology, Chaim Sheba Medical Center, Chaim Sheba Medical Center, Fudan University - Department of Thoracic SurgeryFudan University - Shanghai Cancer Center, King Hussein Cancer Center (KHCC), Tokyo Medical and Dental University, University of Copenhagen - Rigshospitalet, I.M. Sechenov First Moscow State Medical University, Hospital Vall d’Hebron, Vall d’Hebron Institute of Oncology (VHIO)Hospital Vall d’Hebron, McGill University - Segal Cancer Center, McGill University - Segal Cancer Center, Tata Memorial Centre - Tata Memorial Hospital, Institut Mutualiste Montsouris, University of Claude Bernard Lyon 1 - Medical Oncology Department, École Normale Supérieure - PSL Research University - Institut Curie, Iuliu Hatieganu University of Medicine and Pharmacy, Ben-Gurion University of the NegevIuliu Hatieganu University of Medicine and Pharmacy, Ben-Gurion University of the NegevIuliu Hatieganu University of Medicine and Pharmacy, WIN Consortium - Worldwide Innovative Network (WIN) Association and WIN Consortium - Worldwide Innovative Network (WIN) Association

Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Institute of Oncology (VHIO), University of Montreal - Faculté de Pharmacie, Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Institute of Oncology (VHIO), Université de Montréal - Faculty of Pharmacy, University Health Network - Princess Margaret Bioinformatics and Computational Genomics Laboratory, University Health Network - Princess Margaret Bioinformatics and Computational Genomics Laboratory, Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Institute of Oncology (VHIO), Hospital Vall d’Hebron, Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Institute of Oncology (VHIO)Hospital Vall d’Hebron, Vall d’Hebron Institute of Oncology (VHIO) and Vall d’Hebron Institute of Oncology (VHIO)

Vall d’Hebron Institute of Oncology (VHIO), affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, Vall d’Hebron Institute of Oncology (VHIO), affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Institute of Oncology (VHIO)Hospital Vall d’Hebron, Hospital Vall d’Hebron, Vall d’Hebron Institute of Oncology (VHIO) and Vall d’Hebron Institute of Oncology (VHIO)